M&A M&A
Drugmaker Lupin’s subsidiary acquires Netherlands-based ophthalmic solutions provider VISUfarma
Source Business Line (opens in a new tab)BSE Announcement (opens in a new tab)
Mumbai-based drug maker Lupin, via its subsidiary Nanomi B.V. (Nanomi), has acquired Amsterdam-headquartered VISUfarma BV , a portfolio company of global healthcare specialist investor GHO Capital Partners LLP at an enterprise value of EUR 190 million. Lupin will finance the acquisition cost through existing cash in the balance sheet.VISUfarma is a specialty pharmaceutical company focused on ophthalmology and sells products in the areas of dry eye, glaucoma, eyelid hygiene, blepharitis, retinal health and highly focused nutraceuticals prescribed by ophthalmologists.